Delaware Court Rules That Watson Does Not Infringe Patent Related to Generic Version of Concerta and Declares Patent Invalid

CORONA, Calif., March 31, 2009 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced today that the United States District Court for the District of Delaware has ruled that Watson's generic...

Comments

Comments are closed.